Statistics

Total Visits

Views
Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer75

Select a period of time:

Number of views in the range

Views
Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer39

Views

Views
June 20250
July 202524
August 20250
September 20252
October 20252
November 20259
December 20252
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil17
United States11
United Kingdom4
Argentina1
Colombia1
Ethiopia1
Kenya1
Nicaragua1
Portugal1
South Africa1
 

Top cities views

Views
Rio de Janeiro2
Addis Ababa1
Ashburn1
Avaré1
Bugalagrande1
Chicago1
Durban1
Foz do Iguaçu1
Gramado1
Guarulhos1